View Press Releases
-
OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform
Sep 29, 2025
-
Oklahoma’s Largest Locally Owned Health Plan Selects 1upHealth as a Strategic Interoperability Partner
Sep 29, 2025
-
Clearwater Receives Strategic Growth Investment from Sunstone Partners
Sep 29, 2025
-
ZeOmega Named Leader in Everest Group’s PEAK® Matrix Assessment for Second Consecutive Year
Sep 28, 2025
-
Symbiosis Expands Sterile Manufacturing Capacity with Fill/Finish Line Qualification
Sep 29, 2025
-
P&C Labs Achieves Immediate Efficiency Gains with Proscia’s Software
Pathologists readily embrace the shift to digital workflows.
Sep 29, 2025
-
Hovione and Microinnova partner to advance modular flow chemistry for multi-purpose manufacturing
Sep 25, 2025
-
Proscia to Expand Pathology AI Capabilities with Virtual Staining
Delivering a menu of H&E, IHC, and special stains on the Concentriq platform
Sep 23, 2025
-
PubHive Introduces Generative AI Usage Dashboard to Advance Governance and Cost Efficiency in Life Sciences
PubHive launches Generative AI Usage Dashboard to give life sciences teams visibility, compliance, and cost control for responsible AI adoption.
Sep 24, 2025
-
Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity
Sep 23, 2025
-
Takara Bio Europe Launches Cellartis® MSC EV Wonder™, a Defined, Xeno-Free Medium for High-Yield EV Production
Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder.
Sep 23, 2025
-
Arkivum announces new partnership with unified trial management platform provider PHARMASEAL
Arkivum is delighted to announce a new partnership with PHARMASEAL, the provider of the Engility® Trial Management Platform, consisting of a Clinical Trial Management System (CTMS) and Electronic Trial Master File (eTMF).
Sep 17, 2025
-
Abselion Introduces Protein G Total Antibody Quantification Kit
New kit enables rapid, accurate titre measurement across broad range of IgG subclasses and species on Amperia platform
Sep 21, 2025
-
Huateng Pharma Highlights Key Intermediate for Aficamten
Hunan Huateng Pharmaceutical Co., Ltd. provides 1-Methyl-1H-Pyrazole-4-Carboxylic Acid (CAS 5952-92-1), a high-purity intermediate used in the synthesis of Aficamten (CK-274), an investigational cardiac myosin inhibitor currently in Phase 3 trials for hypertrophic cardiomyopathy.
Sep 21, 2025
-
Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms
Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms
Sep 16, 2025
-
Ardent Health Announces Enterprise Rollout of Ambience Healthcare's AI Platform for Documentation, Coding and Clinical Workflows
Sep 16, 2025
-
Carolina Molecular Inc. and Astoriom to Collaborate on Integrated Molecular Testing and Biospecimen Storage Services
Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners
Sep 15, 2025
-
BMJ Group report reveals digital health expectation gap, with healthcare professionals left waiting for productivity gains
Sep 16, 2025
-
Proscia Expands AWS Collaboration to Advance Precision Medicine with AWS HealthImaging Integration
AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform
Sep 15, 2025
-
FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium to Enable Gene Therapy Production
• First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures • Additional capabilities for continuous Adeno-Associated Virus (AAV) and Lentivirus (LV) production for consistent quality, performance, and scalability
Sep 14, 2025


